Everything tagged "cash flow" across the TickerSpark archives.
Tyler Technologies is a high-quality public-sector software compounder with rising recurring revenue, strong cash generation, and a premium valuation that demands discipline.
EMCOR delivered record 2025 revenue, expanding margins, and a conservative balance sheet while demand in data centers and electrical construction accelerated. The stock looks expensive, but execution and backlog growth support a constructive Buy view.
Hilton is a high-quality, asset-light lodging platform with strong fee growth, a record pipeline, and powerful loyalty economics. The stock looks like a solid business trading close to fair value, limiting upside from here.
Visa is still compounding at a high rate, with double-digit revenue growth, expanding value-added services, and strong cash generation. The main debate is valuation, not business quality.
Union Pacific remains a high-quality freight rail compounder with strong margins, durable cash flow, and a hard-to-replicate western network. The stock looks attractive on pullbacks, but current valuation keeps the recommendation at Hold.
ServiceNow is still compounding at a high rate, with 20%+ revenue growth, expanding margins, and strong free cash flow. The report argues the stock remains a premium but attractive long-term platform play as AI deepens its workflow moat.
Teledyne Technologies posted record 2025 orders, sales, and profitability, with strong cash flow and broad-based growth across imaging, instrumentation, and defense electronics. The stock looks like a high-quality compounder, but the valuation already reflects much of the near-term upside.
Tractor Supply is digesting a temporary earnings slowdown, but its needs-based demand, store growth, and strong cash generation remain intact. The stock looks like a selective Buy on weakness rather than a broken retailer.
UnitedHealth is still a healthcare giant, but 2025 exposed a sharp margin reset driven by medical cost inflation and OptumHealth weakness. The stock looks like a Buy for medium-term investors if management can keep the 2026 repair on track.
CCEP delivered record 2025 revenue, margin expansion, and strong free cash flow, reinforcing its case as a steady compounder. The main debate is valuation, not business quality, with buybacks and dividends supporting returns.
Chevron is executing well operationally, with 2025 production up 12% and a stronger portfolio after Hess, but the stock still faces a valuation and oil-price overhang. The report rates CVX a Buy on weakness for medium-term investors.
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the GeneratorCancel anytime